Acylation of hindered amines and functionalized bis-peptides obtained thereby
AssigneesTemple University of the Commonwealth System of Higher Education, University of Pittsburgh—Of the Commonwealth System of Higher Education
InventorsChristian E. Schafmeister, Zachary Z. Brown
Life of this patent
Estimating the term…
Abstract
Functionalized bis-peptides as well as other amide-containing compounds are obtained by acylation of hindered amines. The functionalized bis-peptides are useful as shape-programmable nanostructures that are immune to denaturation and that contain arrays of functional groups having designed catalytic, protein-binding and/or sensor capabilities.
Claims9
A bis-peptide comprising a plurality of 2,5-diketopiperazine rings, wherein at least one 2,5-diketopiperazine ring contains a tertiary amide nitrogen atom bearing a pendant functional group, wherein the bis-peptide has a structure:
- DKP1(X1)-L1-[-DKP2(X2)-L2-]q-DKP3(X3)
- wherein q is 0 or an integer of from 1 to 50;
- DKP1, DKP2 and DKP3 are 2,5-diketopiperazine rings;
- X1, X2 and X3 are the same or different and are hydrogen or functional groups attached to an amide nitrogen atom of the 2,5-diketopiperazine ring, subject to the provisos that i) at least one of X1, X2 or X3 is a pendant functional group which is not hydrogen and ii) when q is greater than 1, X2 may differ among the -DKP2(X2)-L2-repeating units;
- and L1 and L2 are the same or different and are linking moieties, subject to the proviso that when q is greater than 1, L2 may differ among the -DKP2(X2)-L2-repeating units;
- the pendant functional group has a structure CH(R1)(R2) and R1 and R2 are each independently selected from the group consisting of hydrogen, Ar, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl, (C5-C7)-cycloalkyl substituted (C3-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl, (C5-C7)-cycloalkenyl substituted (C3-C6)-straight or branched alkenyl or alkynyl, Ar-substituted (C1-C6)-straight or branched alkyl, Ar-substituted (C3-C6)-straight or branched alkenyl or alkynyl;
- wherein any one of the CH2 groups of said alkyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO2, and NR;
- wherein R is selected from the group consisting of hydrogen, (C1-C4)-straight or branched alkyl , (C3-C4)-straight or branched alkenyl or alkynyl, and (C1-C4) bridging alkyl wherein a bridge is formed between the nitrogen and a carbon atom of said heteroatom-containing chain to form a ring, and wherein said ring is optionally fused to an Ar group;
- wherein Ar is a carbocyclic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl;
- or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl , oxazolyl, thiazolyl, imidazolyl, pyraxolyl, 2-pyrazolinyl, gyrazolidinyl, isoxazolyl, isotriazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazol 1,3,4-thiadiazol pyridazinyl, pyrimidinyl, pyrazinyl 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl 1H-indazol, benzimidazol benzthiazol purinyl, 4H-quinolizinyl, quinolinyl, 1,2,3,4-tetrahydroguinolinyl, isoquinolinyl, 1,2,3,4-tetrahydroisoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl;
- wherein Ar is optionally substituted with one or more substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, —SO3H, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, —O—[(C1-C6)-straight or branched alkyl], —O—[(C3-C4)-straight or branched alkenyl], —O-benzyl, —O-phenyl, 1,2-methylenedioxy, —NR5R6, carboxyl, —N—(C1-C5-straight or branched alkyl or C3-C5-straight or branched alkenyl) carboxamides, —N,N-di-(C1-C5-straight or branched alkyl or C3-C5-straight or branched alkenyl) carboxamides, morpholinyl, piperidinyl, —O-M, —CH2—(CH2)r-M, —O—(CH2)r-M, —(CH2)r—O—M, and —CH═CH-M;
- wherein R5 and R6 are independently selected from the group consisting of hydrogen, (C1-C6)-straight or branched alkyl, (C3-C6)-straigdht or branched alkenyl or alkynyl and benzyl;
- wherein M is selected from the group consisting of 4-methoxyphenyl, 2-pyridyl, 3-pyridyl,4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, 2-methylthiazoyl , thiazoyl, 2-thienyl, 3-thienyl and pyrimidyl;
- and r is 0-2;
- and
- each of L1and L2 independently consists of i) two —CH2— groups, ii) a —CH2— and a —CH2CH2— group or iii) a tetravalent —CH(CH2—)—CH(CH2—)(CH2CH2—) group, which are or is part of a ring structure which also includes an amide nitrogen and a carbon atom of one 2,5-diketopiperazine ring and a carbon atom of the adjacent 2,5-diketopiperazine ring.
Dependencies are inferred from the claim text.